Simvastatin Combined With Ramipril Treatment in Hypercholesterolemic Patients

No abstract is available for this paper.

• Publication year

  2004

• Venue

  HYPERTENSION

• Publication date

  2004-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.HYP.0000133310.42762.25PMID 15184351
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• C-Reactive Protein Upregulates Angiotensin Type 1 Receptors in Vascular Smooth Muscle

  2003cited by this paper
• Effect of hormone replacement therapy on tissue factor activity, C-reactive protein, and the tissue factor pathway inhibitor.

  2003cited by this paper
• Comparative Effects of Diet and Statin on NO Bioactivity and Matrix Metalloproteinases in Hypercholesterolemic Patients With Coronary Artery Disease

  2002cited by this paper
• The AT1-Type Angiotensin Receptor in Oxidative Stress and Atherogenesis

  2002cited by this paper
• MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Commentary

  2002cited by this paper
• MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.

  2002cited by this paper
• The AT(1)-type angiotensin receptor in oxidative stress and atherogenesis: part I: oxidative stress and atherogenesis.

  2002cited by this paper
• Prognostic Value of Coronary Vascular Endothelial Dysfunction

  2002cited by this paper
• Simvastatin Prevents Angiotensin II–Induced Cardiac Alteration and Oxidative Stress

  2002cited by this paper
• Blood-pressure reduction and cardiovascular risk in HOPE study.

  2001cited by this paper
• Endothelial Dysfunction, Oxidative Stress, and Risk of Cardiovascular Events in Patients With Coronary Artery Disease

  2001cited by this paper
• Vascular Effects of Synthetic or Natural Progestagen Combined With Conjugated Equine Estrogen in Healthy Postmenopausal Women

  2001cited by this paper
• Angiotensin II–Induced Hypertension Accelerates the Development of Atherosclerosis in ApoE-Deficient Mice

  2001cited by this paper
• HMG CoA Reductase Inhibitors Reduce Plasminogen Activator Inhibitor-1 Expression by Human Vascular Smooth Muscle and Endothelial Cells

  2000cited by this paper
• Endothelium-dependent responses in patients with hypercholesterolemic coronary artery disease under the effects of simvastatin and enalapril, either separately or combined.

  2000cited by this paper
• Effects of statins on vascular wall: vasomotor function, inflammation, and plaque stability.

  2000cited by this paper
• Angiotensin II stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor-kappaB activation induced by intracellular oxidative stress.

  2000cited by this paper
• Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

  2000cited by this paper
• Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice.

  2000cited by this paper
• HMG CoA reductase inhibitors reduce plasminogen activator inhibitor-1 expression by human vascular smooth muscle and endothelial cells.

  2000cited by this paper
• Long-Term Effects of Cholesterol Lowering and Angiotensin-Converting Enzyme Inhibition on Coronary Atherosclerosis: The Simvastatin/Enalapril Coronary Atherosclerosis Trial (SCAT)

  2000cited by this paper
• Statin-sensitive dysregulated AT1 receptor function and density in hypercholesterolemic men.

  1999cited by this paper
• Vascular effects of estrogen and cholesterol-lowering therapies in hypercholesterolemic postmenopausal women.

  1999cited by this paper
• Mechanism by which quinapril improves vascular function in coronary artery disease.

  1999cited by this paper
• The angiotensin-converting enzyme inhibitor, fosinopril, and the angiotensin II receptor antagonist, losartan, inhibit LDL oxidation and attenuate atherosclerosis independent of lowering blood pressure in apolipoprotein E deficient mice.

  1999cited by this paper
• Hypercholesterolemia is associated with enhanced angiotensin AT1-receptor expression.

  1997cited by this paper
• Effects of hormone-replacement therapy on fibrinolysis in postmenopausal women.

  1997cited by this paper
• Upregulation of vascular angiotensin II receptor gene expression by low-density lipoprotein in vascular smooth muscle cells.

  1997cited by this paper
• Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study.

  1996cited by this paper
• Nitric oxide modulates the expression of monocyte chemoattractant protein 1 in cultured human endothelial cells.

  1995cited by this paper
• Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells. A potential link between the renin-angiotensin system and thrombosis.

  1995cited by this paper
• The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion.

  1995cited by this paper
• Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells.

  1994cited by this paper
• NADH oxidoreductase is a major source of superoxide anion in bovine coronary artery endothelium.

  1994cited by this paper
• Metabolism and excretion of nitric oxide in humans. An experimental and clinical study.

  1993cited by this paper
• Stimulation of Plasminogen Activator Inhibitor In Vivo by Infusion of Angiotensin II Evidence of a Potential Interaction Between the Renin‐Angiotensin System and Fibrinolytic Function

  1993cited by this paper
• Negative feedback regulation of endothelial cell function by nitric oxide.

  1993cited by this paper
• Kinins and endothelium-dependent relaxations to converting enzyme inhibitors in perfused canine arteries.

  1991cited by this paper
• An Experimental and Clinical Study

  1966cited by this paper

• The cardiovascular polypill as baseline treatment improves lipid profile and blood pressure regardless of body mass index in patients with cardiovascular disease. The Bacus study

  2023cites this paper
• The Framingham Study on Cardiovascular Disease Risk and Stress-Defenses: A Historical Review

  2023cites this paper
• Monocyte chemoattractant protein-1 and hypertension: An overview.

  2021cites this paper
• The Comparison of Antioxidant Effect of Aspirin, Metformin, Atorvastatin and Captopril Co-administration in the Heart and Kidney Tissues of Diabetic Rats

  2021cites this paper
• Comparison of the Neuroprotective Effects of Aspirin, Atorvastatin, Captopril and Metformin in Diabetes Mellitus

  2019cites this paper
• Does Co-administration of Antihypertensive Drugs and Statins Alter Their Efficacy and Safety? A Systematic Review and Meta-analysis of Randomized Controlled Trials.

  2019cites this paper
• Effects of combined statin and ACE inhibitor therapy on endothelial function and blood pressure in essential hypertension - a randomised double-blind, placebo controlled crossover study

  2019cites this paper
• Effect of statin treatment on circulating malondialdehyde concentrations: a systematic review and meta-analysis

  2019cites this paper
• Renin-angiotensin system at the crossroad of hypertension and hypercholesterolemia.

  2017cites this paper
• Antioxidant properties of drugs used in Type 2 diabetes management: could they contribute to, confound or conceal effects of antioxidant therapy?

  2017cites this paper
• In Patients with Cardiovascular Disease, Do Statins Alone, or in Combination with Other Medications Improve Mortality?

  2017cites this paper
• Rosuvastatin dose-dependently improves flow-mediated dilation, but reduces adiponectin levels and insulin sensitivity in hypercholesterolemic patients.

  2016cites this paper
• nflammatory Markers and the Metabolic Syndrome nsights From Therapeutic Interventions

  2016cites this paper
• Renin-Angiotensin System Blockade Associated with Statin Improves Endothelial Function in Diabetics

  2015cites this paper
• Statins, the renin–angiotensin–aldosterone system and hypertension – a tale of another beneficial effect of statins

  2014cites this paper
• Relationship between endothelial dysfunction and cardiovascular risk factors and the extent and severity of coronary artery disease.

  2014cites this paper
• Relationship between endothelial dysfunction and cardiovascular risk factors and the extent and severity of coronary artery disease Endotel fonksiyonu bozukluğu ile kalp damar hastaliği risk faktörleri ve koroner arter hastaliği yayginliği ve ciddiyeti arasindaki ilişki

  2014cites this paper
• Combination Pravastatin and Valsartan Treatment Has Additive Beneficial Effects to Simultaneously Improve Both Metabolic and Cardiovascular Phenotypes Beyond That of Monotherapy With Either Drug in Patients With Primary Hypercholesterolemia

  2013cites this paper
• Diabetes and Hypertension: Is There a Common Metabolic Pathway?

  2012cites this paper
• Effects of combining simvastatin with rosiglitazone on inflammation, oxidant stress and ambulatory blood pressure in patients with the metabolic syndrome: the SIROCO study

  2012cites this paper
• Simvastatin enhances the antihypertensive effect of ramipril in hypertensive hypercholesterolemic animals and patients. Possible role of nitric oxide, oxidative stress, and high sensitivity C‐reactive protein

  2012cites this paper
• Meta-analysis of the effects of statin therapy on endothelial function in patients with diabetes mellitus.

  2012cites this paper
• Angiotensin converting enzyme inhibitors effect on endothelial dysfunction: a meta-analysis of randomised controlled trials.

  2011cites this paper
• Combination therapy of candesartan with statin inhibits progression of atherosclerosis more than statin alone in patients with coronary artery disease

  2011cites this paper
• A Randomized Trial Comparing the Effect of Ramipril and Losartan in Survivors of ST-Elevation Myocardial Infarction

  2009cites this paper
• MULTIORGAN-PROTECTIVE ACTIONS OF BLOCKERS OF THE RENIN-ANGIOTENSIN SYSTEM, STATINS AND ERYTHROPOIETIN: COMMON PLEIOTROPIC EFFECTS IN RENO-, CARDIO- AND NEUROPROTECTION

  2008cites this paper
• [Effects of ramipril and simvastatin on the oxidative stress of diabetic rats].

  2008cites this paper
• Simvastatin reverses the hypertension of heterozygous mice lacking cystathionine β-synthase and apolipoprotein A-I

  2008cites this paper
• Monocyte chemoattractant protein-1 and atherosclerosis: is there room for an additional biomarker?

  2007cites this paper
• Effect of sulfhydryl and non-sulfhydryl angiotensin-converting enzyme inhibitors on endothelial function in essential hypertensive patients.

  2007cites this paper
• EGCG, a green tea polyphenol, improves endothelial function and insulin sensitivity, reduces blood pressure, and protects against myocardial I/R injury in SHR.

  2007cites this paper
• Comparison of cardiovascular events in patients with angiographically documented coronary narrowing with combined renin-angiotensin system inhibitor plus statin versus renin-angiotensin system inhibitor alone versus statin alone (from the Japanese Coronary Artery Disease Study).

  2007cites this paper
• Statins: a new insight into their mechanisms of action and consequent pleiotropic effects.

  2007cites this paper
• Vascular inflammation in hypertension and diabetes: molecular mechanisms and therapeutic interventions.

  2007cites this paper
• Inflammatory process in type 2 diabetes: The role of cytokines.

  2006cites this paper
• Early effects on endothelial function of atorvastatin 40 mg twice daily and its withdrawal.

  2006cites this paper
• Inflammatory Process in Type 2 Diabetes

  2006cites this paper
• Vascular Endothelium and Effects of the Statins

  2006cites this paper
• Ramipril: a review of its use in preventing cardiovascular outcomes in high-risk patients.

  2006cites this paper
• Pravastatin decreases blood pressure in hypertensive and hypercholesterolemic patients receiving antihypertensive treatment.

  2006cites this paper
• Simvastatin treatment improves endothelial function and increases fibrinolysis in patients with hypercholestrolemia.

  2006cites this paper
• Vascular adrenergic tone and structural narrowing constrain reactive hyperemia in skeletal muscle of obese Zucker rats.

  2006cites this paper
• Effect of Atorvastatin and Irbesartan, Alone and in Combination, on Postprandial Endothelial Dysfunction, Oxidative Stress, and Inflammation in Type 2 Diabetic Patients

  2005cites this paper
• Inflammatory markers and the metabolic syndrome: insights from therapeutic interventions.

  2005cites this paper
• Mechanisms of endothelial dysfunction in obesity.

  2005cites this paper
• The clinical significance of endothelial dysfunction

  2005cites this paper
• Vascular and Metabolic Effects of Combined Therapy With Ramipril and Simvastatin in Patients With Type 2 Diabetes

  2005cites this paper
• Classical Anti-oxidants (Scavengers) versus Biological Anti-oxidants (Suppressors of ROS Generation): ANovel Way to Explain the Anti-oxidant Paradox

  2004cites this paper